Project Grant R21AI196623
Award Date 4/17/26
Completion Date 3/31/28
Dollars Obligated $86K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Fort Worth, TX 76107, USA
Similar Awards
- Summary Under a $234,292 Project Grant awarded September 13, 2025, by the Fogarty International Center (CFDA 93.989: International Research and Research Training), Impact Research and Development Organisation will develop and pilot test a multilevel, community-based intervention to reduce Pre-Exposure Prophylaxis (PrEP) stigma and increase PrEP uptake among adolescent girls and young women (AGYW) ages 15–24 in western Kenya. The project addresses a critical public health gap, as AGYW represent...
- HEP C FREE Puerto Rico Integrated Care Pilot – Award Summary Mennonite General Hospital, Inc. (MGHPR) received a $7.5 million Project Grant from the Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance Abuse Treatment under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243). The award, effective September 30, 2025, through September 29, 2027, funds an integrated hepatitis C (HCV) care pilot...
- PHARMA-GIRL Project Grant Summary The University of California, San Francisco received a $408,643 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) for the period February 1, 2026 through January 31, 2028. The PHARMA-GIRL project conducts implementation science research to evaluate pharmacy-based HIV prevention and treatment service delivery models targeting adolescent...
- Hepatitis B and HIV Cure Consortium (BICC) Cooperative Agreement Summary The National Institute of Allergy and Infectious Diseases awarded a $11.0 million Cooperative Agreement to Johns Hopkins University on September 26, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to establish and operate the Hepatitis B and HIV Cure Consortium (BICC). This multinational research initiative delivers comprehensive services to advance hepatitis B virus (HBV) functional cure...
- Federal Project Grant Award Summary The University of Alabama at Birmingham received a $453,804 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective September 3, 2025, through August 31, 2027. This award supports the "Pharmacy-Centered Rapid ARV Network: Capacity-Building for Status-Neutral ART/PrEP Services Within Southern Community Pharmacies" initiative, which...
- Federal Grant Award Summary The National Institute of Nursing Research (CFDA 93.361, Nursing Research program) awarded The Johns Hopkins University a $157,614 project grant effective March 1, 2026 through June 30, 2028 to conduct a mixed-methods study examining health-related quality of life (HRQOL) among adolescents and young adults (AYAs) living with chronic hepatitis B (CHB). The research will deliver quantitative analysis utilizing the Hepatitis B Research Network Pediatric Cohort Study...
- This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $381,487 to the University of Maryland, Baltimore (UMB) to assess the early implementation of long-acting injectable cabotegravir (CAB-LA) pre-exposure prophylaxis (PrEP) among adolescent girls and young women (AGYW) at high risk of HIV acquisition in Zambia. The key objectives are to: 1) Evaluate implementation determinants of CAB-LA...
- Federal Project Grant Award Summary Emory University received a $954,603 project grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) awarded April 9, 2026, with completion targeted for March 31, 2028. The award funds the development of a biodegradable and biocompatible nanoparticle injectable sterile formulation that encapsulates ALG-001075, a novel capsid assembly modulator with pan-genotypic...
- Federal Grant Award Summary: HIP-PHARM Project Wake Forest University Health Sciences received a $1.55 million Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective July 1, 2025, through March 31, 2030. The HIP-PHARM (Integrated HIV and Overdose Prevention in Pharmacies) project delivers a comprehensive research assessment of HIV pre-exposure prophylaxis (PrEP) and overdose prevention service...
- Federal Project Grant Award Summary Weill Medical College of Cornell University received a $806,208 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded September 4, 2025, with completion targeted for August 31, 2030. This award supports research utilizing cutting-edge spatial proteomics and transcriptomics technologies to investigate hepatitis B virus (HBV) control and persistence...